期刊文献+

DBC2基因诱导乳腺癌细胞周期G_1期阻滞的机制 被引量:3

Mechanisms of DBC2 Inducing the Cell Cycle G_1 Arrest in Breast Cancer Cell Line
下载PDF
导出
摘要 目的研究肿瘤抑癌基因DBC2(deletion in breast cancer2)抑制乳腺癌MDA-MB-435S细胞增殖的可能机制。方法野生型DBC2基因的真核表达载体pEBG-DBC2瞬时转染MDA-MB-435S细胞72h,RT-PCR方法证实DBC2基因的过表达;流式细胞术检测DBC2的瞬时过表达对MDA-MB-435S细胞周期的影响,Western blot检测DBC2的过表达对细胞周期蛋白CyclinD1表达的作用。结果DBC2基因在MDA-MB-435S细胞中瞬时转染72h后,其mR-NA表达水平即可成倍增加,同时DBC2基因的过表达可诱导该乳腺癌细胞周期的G1期阻滞,并随着时间的延长出现细胞凋亡。结论DBC2基因体外抑制乳腺癌细胞生长的功能,可能通过抑制CyclinD1的表达并使细胞停滞于G1期,以及诱导细胞凋亡等机制实现。 Objective To discuss the probable mechanisms by which DBC2 inhibits proliferation of MDA-MB-435S breast cancer cell line in vitro. Methods Transient DBC2 over-expression in MDA-MB-435S cell line was generated by lipofectamine2000 transfection, and RT-PCR was performed to verify the over-expression of DBC2 mRNA. The effects of transient DBC2 over-expression was checked by flow cytometry. Western blot was used to evaluate the cell cycle related protein expression. Results The expression of DBC2 mRNA was twice more than the control group after transient transfection of pEBG-DBC2 for 72 h in MDA-MB-435S breast cancer cell line. The over-expression of DBC2 could significantly induce cell cycle G1 arrest during 48 to 72 h in vitro, and induce apoptosis after 72 h. DBC2 could also decrease the expression of Cyclin DI protein. Conclusion Transient over-expression of DBC2 in vitro could inhibit the growth of breast cancer cells, possibly through the mechanisms of decreasing the expression of Cyclin D1, inducing G1 cell cycle arrest and apoptosis.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2008年第1期48-50,54,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 国家自然科学基金资助项目(No30400432)
关键词 DBC2基因 细胞周期 乳腺癌 细胞周期蛋白 DBC2 gene cell cycle breast cancer Cyclin D1
  • 相关文献

参考文献9

  • 1VOGELSTEIN B, KINZLER K W. Cancer genes and the pathways they control [J]. Nat Med, 2004, 10(8):789-799.
  • 2ANTONIOU A C, EASTON D F. Models of genetic susceptibility to breast cancer [J]. Oncogene, 2006, 25(43):5898-5905.
  • 3MENG Z H, BEN Y, LI Z, et al. Aberrations of breast cancer susceptibility genes occur early in sporadic breast tumors and in acquisition of breast epithelial immortalization [J]. Genes Chromosomes Cancer, 2004, 41 (3) : 214-222.
  • 4SHERR C J. Principles of tumor suppressor [J]. Cell, 2004, 116 (2) :235-246.
  • 5HAMAGUCHI M, WIGLER M H. DBC2, a tumor suppressor gene involved in breast cancer [J]. Proc Natl Acad Sci USA, 2002, 99(21) :13647-13652.
  • 6HO A, DOWDY S F. Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes [J]. Curr Opin Genet Dev, 2002, 12(1):47-52.
  • 7FU M, WANG C, LI Z, et al. Minireview: Cyclin Dl : normal and abnormal functions [J]. Endocrinology, 2004, 145(12):5439- 5447.
  • 8SEVILLE L L, SHAH N, WESTWELL A D, et al. Modulation of pRB/E2F functions in the regulation of cell cycle and in cancer [J]. Curr Cancer Drug Targets, 2005, 5(3) : 159-170.
  • 9TASHIRO E, TSUCHIYA A, IMOTO M. Functions of Cyclin D1 as an oncogene and regulation of Cyclin D1 expression [J]. Cancer Sci, 2007, 98(5) :629-635.

同被引文献27

  • 1Rakha EA,Reis-Filho JS,Ellis IO. Combinatiorial biomarker expression in breast cancer[J].Breast Cancer Research and Treatment,2010.293-308.
  • 2Jang JS,Kim KM,Choi JE. Identification of polymorphisms in the Caspase-3 gene and their association with lung cancer risk[J].Molecular Carcinogenesis,2008.383-390.
  • 3Xu HL,Xu WH,Cai Q. Polymorphisms and haplotypes in the caspase-3,caspase-7,caspase-8 gene and risk for endometrial cancer:a population-based,case-control study in a Chinese population[J].Cancer Epidemiology Biomarkers and Prevention,2009.2114-2122.
  • 4Wesierska-Gadek J,Hackl S,Zulehner N. Reconstitution of human MCF-7 breast cancer cells with caspase-3 does not sensitize them to action of CDK inhibitors[J].Journal of Cellular Biochemistry,2011.273-288.
  • 5Wang Z,Dong H,Fu Y. RAD51 135G》C polymorphism contrbutes to cancer susceptibility.a meta-analysis involving 26,444 subjects[J].Breast Cancer Research and Treatment,2010.765-769.
  • 6Romanowicz-Makowska H,Smolarz B,Zadrozny M. Analysis of RDA51 polymorphism and BRCA1 mutations in Polish women with breast cancer[J].Experimental Oncology,2006.156-159.
  • 7Tanaja P,Maglic D,Kal F. Classical and novel prognostic markers for breast cancer and their clinical significance[J].Clin Med Insights Oncol,2010.15-34.
  • 8Perou CM,Sorlie T,Eisen MB. Molecular portraits of human breast rumours[J].Nature,2000.747-752.
  • 9Munirah MA,Siti-Aishah MA,Reena MZ. Identification of different subtypes of breast cancer using tissue microarray[J].Romanian Journal of Morphology and Embryology,2011.669-677.
  • 10Cheang MC,Voduc D,Bajdik C. Basal-like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype[J].Clinical Cancer Research,2008.1368-1376.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部